Published in Pol Tyg Lek on October 13, 1986
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47
Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation (2000) 5.09
ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation (1995) 3.79
Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation (2000) 2.95
Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation (1998) 2.53
Gender-related differences in thrombogenic factors predicting recurrent cardiac events in patients after acute myocardial infarction. The THROMBO Investigators. Am J Cardiol (2000) 1.47
Prognostic value of cholesterol in women of different ages. J Womens Health (1997) 1.42
Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS Investigators. Circulation (1998) 1.39
Thrombogenic factors and recurrent coronary events. Circulation (1999) 1.38
Normalization of ventricular repolarization with flecainide in long QT syndrome patients with SCN5A:DeltaKPQ mutation. Ann Noninvasive Electrocardiol (2001) 1.33
Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol (1999) 1.25
Sudden cardiac death, genes, and arrhythmogenesis : consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I. Circulation (2001) 1.01
Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients. Thrombogenic Factors, and Recurrent Coronary Events Investigators. Circulation (2000) 0.99
Sudden cardiac death, genes, and arrhythmogenesis: consideration of new population and mechanistic approaches from a National Heart, Lung, and Blood Institute workshop, Part II. Circulation (2001) 0.93
Clinical implications for affected parents and siblings of probands with long-QT syndrome. Circulation (2001) 0.92
Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction. J Thromb Haemost (2004) 0.92
Clinical and genetic variables associated with acute arousal and nonarousal-related cardiac events among subjects with long QT syndrome. Am J Cardiol (2000) 0.92
Comparability of nonlinear measures of heart rate variability between long- and short-term electrocardiographic recordings. Am J Cardiol (2001) 0.91
Fractal correlation properties of heart rate dynamics and adverse events in patients with implantable cardioverter-defibrillators. Am J Cardiol (2001) 0.90
ISHNE guidelines for electrocardiographic evaluation of drug-related QT prolongation and other alterations in ventricular repolarization: task force summary. A report of the Task Force of the International Society for Holter and Noninvasive Electrocardiology (ISHNE), Committee on Ventricular Repolarization. Ann Noninvasive Electrocardiol (2001) 0.90
Time-domain analysis of beat-to-beat variability of repolarization morphology in patients with ischemic cardiomyopathy. J Electrocardiol (1999) 0.87
Beat-to-Beat repolarization variability in LQTS patients with the SCN5A sodium channel gene mutation. Pacing Clin Electrophysiol (1999) 0.87
Asthma and the risk of cardiac events in the Long QT syndrome. Long QT Syndrome Investigative Group. Am J Cardiol (1999) 0.87
Survival benefit with an implanted defibrillator in relation to mortality risk in chronic coronary heart disease. Am J Cardiol (2001) 0.87
Calculation of QTc duration and variability in the presence of sinus arrhythmia. Am J Cardiol (1995) 0.83
Relation of the leukocyte count to recurrent cardiac events in stable patients after acute myocardial infarction. Am J Cardiol (2001) 0.82
Fractal and complexity measures of heart rate dynamics after acute myocardial infarction. Am J Cardiol (2001) 0.82
ECG features of microvolt T-wave alternans in coronary artery disease and long QT syndrome patients. J Electrocardiol (1998) 0.81
QT interval duration in 24-hour Holter monitoring after different interventional treatment of coronary artery disease in patients after the myocardial infarction. Med Sci Monit (2001) 0.79
Recurrent coronary events are not increased in postinfarction patients with methylenetetrahydrofolate reductase gene C677T polymorphism. Am J Cardiol (2001) 0.79
Clinical implications of silent versus symptomatic exercise-induced myocardial ischemia in patients with stable coronary disease. J Am Coll Cardiol (1997) 0.78
Static and Dynamic Electrocardiographic Patterns Preceding Torsades de Pointes in the Acquired and Congenital Long QT Syndrome. Comput Cardiol (2010) (2010) 0.78
Heart rate variability in patients with congenital long QT syndrome. Ann Noninvasive Electrocardiol (2001) 0.78
A covariance-based algorithm: a novel technique for rhythm discrimination in ICDs. Conf Proc IEEE Eng Med Biol Soc (2008) 0.78
Effect of smoking on lipid and thrombogenic factors two months after acute myocardial infarction. Am J Cardiol (2000) 0.78
Automated latex agglutination and ELISA testing yield equivalent D-dimer results in patients with recent myocardial infarction. THROMBO Research Investigators. Thromb Haemost (1999) 0.77
Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages. Med Sci Monit (2001) 0.76
T-wave morphology can distinguish healthy controls from LQTS patients. Physiol Meas (2016) 0.75
[Complete atrio-ventricular block in acute myocardial infarct]. Kardiol Pol (1973) 0.75
[A case of Wolff-Parkinson-White syndrome with 2 accessory pathways]. Kardiol Pol (1988) 0.75
[Bundle branch blocks in acute myocardial infarct]. Pol Tyg Lek (1976) 0.75
[Comparison of selected physiological indicators and vegetative system tests in a group of turbine assemblers in relation to age and duration of employment]. Med Pr (1983) 0.75
Obesity does not influence electrocardiographic parameters in coronary patients. Am J Cardiol (2000) 0.75
[Bi- and tri-fascicular intraventricular blocks and atrio-ventricular conduction]. Kardiol Pol (1973) 0.75
[Effect of night-shift work on selected physiological indicators in power plant workers]. Med Pr (1983) 0.75
[Perforation of tricuspid valve and pulmonary embolism as a complication of intracardiac stimulation]. Kardiol Pol (1972) 0.75
Principles underlying the use of Holter monitoring to define the efficacy of antiarrhythmic drugs. Coron Artery Dis (1994) 0.75
[Clinical evaluation of irrigor as a drug improving the coronary blood flow]. Wiad Lek (1970) 0.75
[Mitral valve incompetence with the symptoms suggesting mitral valve stenosis]. Kardiol Pol (1968) 0.75
[Cordipine in the treatment of patients with exacerbated coronary disease]. Wiad Lek (1989) 0.75
[Comparative analysis of conservative and surgical treatment of the imminent myocardial infarct]. Z Gesamte Inn Med (1977) 0.75
[Evaluation of regional disorders of left-ventricular contraction by two-dimensional echocardiography]. Pol Tyg Lek (1984) 0.75
[Serotonin and methoxamine in the differential diagnosis of murmurs in mitral and tricuspid insufficiency]. Kardiol Pol (1968) 0.75
[A case of glossopharyngeal neuralgia with paroxysmal asystole]. Neurol Neurochir Pol (1986) 0.75
[Experimental and clinical studies on the preparation aminophos]. Wiad Lek (1966) 0.75
[Early and late results of the implantation of mitral valve prostheses]. Kardiol Pol (1984) 0.75
[Diagnostic difficulties in primary myocarditis]. Pol Tyg Lek (1967) 0.75
[Complications after oral and intravenous administration of amiodarone (cordaron)]. Wiad Lek (1986) 0.75
[Idiopathic paroxysmal ventricular fibrillation]. Kardiol Pol (1973) 0.75
[Opening snap of the mitral valve in the case of mitral stenosis coexisting with aortic insufficiency]. Kardiol Pol (1965) 0.75
[Prevention of thromboembolism in auricular fibrillation in mitral valve disease]. Pol Tyg Lek (1981) 0.75
[Use of platelet function analyzer PFA-100 and whole blood aggregometry to monitor blood platelet sensitivity to acetylsalicylic acid (aspirin). Is it possible to reliably monitor antiplatelet treatment using routine laboratory diagnostic methods?]. Pol Arch Med Wewn (2000) 0.75
[Myocardial infarction after aortocoronary bypass]. Kardiol Pol (1984) 0.75
[Diagnostic value of type M echocardiography and two-dimensional echocardiography in qualifying patients with mitral valve stenosis for surgical treatment]. Kardiol Pol (1984) 0.75
[Effect of propranolol on the ECG in patients with confirmed coronary disease]. Pol Tyg Lek (1978) 0.75
[Early and late results of pacemaker therapy]. Pol Arch Med Wewn (1971) 0.75
[Usefulness of Doppler echocardiography for evaluation of pulmonary hypertension based on the analysis of blood flow through the pulmonary artery]. Kardiol Pol (1989) 0.75
[Evaluation of the effectiveness of the treatment of bacterial endocarditis with penicillin or cefamandole and determining the indications for surgical treatment. Preliminary report]. Kardiol Pol (1988) 0.75
[Amiodarone (Cordaron) in the long-term treatment of recurrent supraventricular tachycardia]. Wiad Lek (1986) 0.75
[Diagnostic value of planar perfusion scintigraphy of the heart using Technetium Tc 99m with methoxy-isobutylisonitrile (MIBI)]. Kardiol Pol (1992) 0.75
Detection of a group of risk factors in coronary disease using a new carriership analysis approach. Am J Cardiol (2000) 0.75
Myocardial perfusion scintigraphy with thallium-201 for prediction of graft patency early after internal mammary artery graft surgery. Cor Vasa (1990) 0.75
[Ambulatory ekg monitoring--development and clinical use of Holter's method]. Pol Tyg Lek (1996) 0.75
[The usefulness of M-mode and two-dimensional echocardiography in the evaluation of early and late results of mitral commissurotomy]. Kardiol Pol (1986) 0.75
[Resuscitation results in 15 cardiological and internal medicine centers in Poland]. Pol Arch Med Wewn (1973) 0.75
[Changes of fibrinogen concentration and their prognostic value in acute myocardial infarct]. Pol Tyg Lek (1981) 0.75
[Clinical and therapeutic aspects of sick sinus syndrome]. Pol Tyg Lek (1976) 0.75
[Cardiac asystole in glossopharyngeal neuralgia]. Kardiol Pol (1987) 0.75
[Lignocaine in the treatment of arrhythmia in acute myocardial infarct]. Wiad Lek (1971) 0.75
Beat-to-beat repolarization variability in amplitude and duration in LQTS patients with the SCN5A sodium channel gene mutation. J Electrocardiol (1998) 0.75
[Dissecting aortic aneurysms with atypical course]. Wiad Lek (1973) 0.75
Malignant T-wave alternans. Circulation (2000) 0.75
[Personal observations of dobutamine effectiveness after surgery with extracorporeal circulation]. Pol Tyg Lek (1989) 0.75
[Unusual musical diastolic murmurs]. Kardiol Pol (1969) 0.75
[Polygraphic studies in primary cardiomyopathies]. Kardiol Pol (1974) 0.75
[Gallop rhythms in myocardial infarct]. Pol Tyg Lek (1973) 0.75
[Diagnostic value of the echocardiographic study of a patient with a ruptured congenital aneurysm of the sinus of Valsalva associated with other congenital heart defects]. Kardiol Pol (1987) 0.75
[Diagnostic value of routine and supplementary electrocardiograms as compared to coronary arteriography and ventriculography in patients with coronary heart disease]. Kardiol Pol (1977) 0.75